Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase 14 (p38α) is a member of the p38 MAPK family of serine/threonine kinases involved in cellular responses to stress and inflammation. Activated primarily by phosphorylation through upstream kinases, p38α regulates gene expression, cell differentiation, apoptosis, and inflammation by phosphorylating key transcription factors and regulatory proteins. The p38 MAPK pathway is a major therapeutic target in diseases driven by inflammation, cancer, and degenerative conditions. Multiple small-molecule inhibitors of p38α have reached clinical evaluation for inflammatory diseases and other disorders, but challenges remain regarding selectivity and safety due to the enzyme’s broad physiological roles
Inhibition of kinase activity by binding to the ATP-binding site Downregulation of proinflammatory mediator synthesis (e.g., TNFα, IL-1) Decreased phosphorylation of downstream substrates (transcription factors, cell cycle regulators)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase 14 (p38α).